Department of Medical Statistics, University Goettingen

Prof. Tim Beißbarth


Group Head Statistical Bioinformatics
Phone:
0551-39-175274
Telefax:
0551-39-4995
E-Mail:
Tim.Beissbarth@ams.med.uni-goettingen.de
Office room:
Humboldtallee 32, GF 137

Short Vita:

Degrees:


Publications

(see also Google Scholar Profile)
  1. Relevance of surgery in patients with non-variceal upper gastrointestinal bleeding.
    Dango S*, Beißbarth T*, Weiss E, Seif Amir Hosseini A, Raddatz D, Ellenrieder V, Lotz J, Ghadimi BM, Beham A.
    Langenbecks Arch Surg. 2017 Jan 14. epub.
  2. Working with Ontologies.
    Kramer F, Beißbarth T.
    Methods Mol Biol. 2017;1525:123-135.
  3. Repeated adjuvant anti-CEA radioimmunotherapy after resection of colorectal liver metastases: Safety, feasibility, and long-term efficacy results of a prospective phase 2 study.
    Sahlmann CO, Homayounfar K, Niessner M, Dyczkowski J, Conradi LC, Braulke F, Meller B, Beißbarth T, Ghadimi BM, Meller J, Goldenberg DM, Liersch T.
    Cancer, 2016 Oct 20, epub.
  4. Neoadjuvant Therapy in Rectal Cancer - Biobanking of Preoperative Tumor Biopsies.
    Jo P, Nietert M, Gusky L, Kitz J, Conradi LC, Müller-Dornieden A, Schüler P, Wolff HA, Rüschoff J, Ströbel P, Grade M, Liersch T, Beißbarth T, Ghadimi MB, Sax U, Gaedcke J.
    Sci Rep. 2016 Oct 18;6:35589.
  5. A simulation framework for correlated count data of features subsets in high-throughput sequencing or proteomics experiments.
    Kruppa J, Kramer F, Beißbarth T, Jung K.
    Stat Appl Genet Mol Biol. 2016 Oct 1;15(5):401-414.
  6. Microenvironmental interactions between endothelial and lymphoma cells: a role for the canonical WNT pathway in Hodgkin lymphoma.
    Linke F, Harenberg M, Nietert MM, Zaunig S, von Bonin F, Arlt A, Szczepanowski M, Weich HA, Lutz S, Dullin C, Janovská P, Krafčíková M, Trantírek L, Ovesná P, Klapper W, Beissbarth T, Alves F, Bryja V, Trümper L, Wilting J, Kube D.
    Leukemia. 2016 Oct 4, epub.
  7. WNT5A: a motility-promoting factor in Hodgkin lymphoma.
    Linke F, Zaunig S, Nietert MM, von Bonin F, Lutz S, Dullin C, Janovská P, Beissbarth T, Alves F, Klapper W, Bryja V, Pukrop T, Trümper L, Wilting J, Kube D.
    Oncogene. 2017 Jan 5;36(1):13-23.
  8. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].
    Sprenger T, Rothe H, Beissbarth T, Conradi LC, Kauffels A, Homayounfar K, Behnes CL, Rödel C, Liersch T, Ghadimi M.
    Chirurg. 2016 Jul;87(7):593-601.
  9. Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer.
    Azizian A, Epping I, Kramer F, Jo P, Bernhardt M, Kitz J, Salinas G, Wolff HA, Grade M, Beißbarth T, Ghadimi BM, Gaedcke J.
    Int J Mol Sci. 2016 Apr 15;17(4):568.
  10. Computational Identification of Key Regulators in Two Different Colorectal Cancer Cell Lines.
    Wlochowitz D, Haubrock M, Arackal J, Bleckmann A, Wolff A, Beißbarth T, Wingender E, Gültas M.
    Front Genet. 2016 Apr 5;7:42.
  11. Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup.
    Sprenger T, Rothe H, Conradi LC, Beissbarth T, Kauffels A, Kitz J, Homayounfar K, Wolff H, Ströbel P, Ghadimi M, Wittekind C, Sauer R, Rödel C, Liersch T.
    Dis Colon Rectum. 2016 May;59(5):377-85.
  12. Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis.
    Metz I*, Beißbarth T*, Ellenberger D, Pache F, Stork L, Ringelstein M, Aktas O, Jarius S, Wildemann B, Dihazi H, Friede T, Brück W, Ruprecht K, Paul F.
    Neurol Neuroimmunol Neuroinflamm. 2016 Feb 2;3(2):e204.
  13. Beta-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases.
    Bleckmann A, Conradi LC, Menck K, Schmick NA, Schubert A, Rietkötter E, Arackal J, Middel P, Schambony A, Liersch T, Homayounfar K, Beißbarth T, Klemm F, Binder C, Pukrop T.
    Clin Exp Metastasis. 2016 Apr;33(4):309-23.
  14. Social defeat leads to changes in the endocannabinoid system: An overexpression of calreticulin and motor impairment in mice.
    Tomas-Roig J, Piscitelli F, Gil V, Del Río JA, Moore TP, Agbemenyah H, Salinas-Riester G, Pommerenke C, Lorenzen S, Beißbarth T, Hoyer-Fender S, Di Marzo V, Havemann-Reinecke U.
    Behav Brain Res. 2016 Apr 15;303:34-43.
  15. Decoding Cellular Dynamics in Epidermal Growth Factor Signaling Using a New Pathway-Based Integration Approach for Proteomics and Transcriptomics Data.
    Wachter A, Beißbarth T.
    Front Genet. 2016 Jan 7;6:351.
  16. EEPD1 Rescues Stressed Replication Forks and Maintains Genome Stability by Promoting End Resection and Homologous Recombination Repair.
    Wu Y, Lee SH, Williamson EA, Reinert BL, Cho JH, Xia F, Jaiswal AS, Srinivasan G, Patel B, Brantley A, Zhou D, Shao L, Pathak R, Hauer-Jensen M, Singh S, Kong K, Wu X, Kim HS, Beißbarth T, Gaedcke J, Burma S, Nickoloff JA, Hromas RA.
    PLoS Genet. 2015 Dec 18;11(12):e1005675.
  17. Newly Constructed Network Models of Different WNT Signaling Cascades Applied to Breast Cancer Expression Data.
    Bayerlova M, Klemm F, Kramer F, Pukrop T, Beißbarth T*, Bleckmann A*.
    PLoS One. 2015 Dec 3;10(12):e0144014.
  18. Perioperative Blood Glucose Levels <150 mg/dL are Associated With Improved 5-Year Survival in Patients Undergoing On-Pump Cardiac Surgery: A Prospective, Observational Cohort Study.
    Mansur A, Popov AF, Hanna AA, Bergmann I, Brandes IF, Beißbarth T, Bauer M, Hinz J.
    Medicine (Baltimore). 2015 Nov;94(45):e2035.
  19. Reconstruction of Protein Networks Using Reverse-Phase Protein Array Data.
    von der Heyde S, Sonntag J, Kramer F, Bender C, Korf U, Beißbarth T.
    Methods Mol Biol. 2016;1362:227-46.
  20. Comparative study on gene set and pathway topology-based enrichment methods.
    Bayerlová M, Jung K, Kramer F, Klemm F, Bleckmann A, Beißbarth T.
    BMC Bioinformatics. 2015 Oct 22;16:334.
  21. TNF-a stimulation enhances ROS-dependent cell migration via NF-?B activation in liver cells.
    Kastl L, Sauer S, Beißbarth T, Becker M, Krammer P, Gülow K.
    Free Radic Biol Med. 2014 Oct;75 Suppl 1:S32.
  22. Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinoma.
    Rave-Fränk M, Tehrany N, Kitz J, Leu M, Weber HE, Burfeind P, Schliephake H, Canis M, Beissbarth T, Reichardt HM, Wolff HA.
    Strahlenther Onkol. 2016 Jan;192(1):47-54.
  23. The putative oncogene CEP72 inhibits the mitotic function of BRCA1 and induces chromosomal instability.
    Lüddecke S, Ertych N, Stenzinger A, Weichert W, Beissbarth T, Dyczkowski J, Gaedcke J, Valerius O, Braus GH, Kschischo M, Bastians H.
    Oncogene. 2015 Aug 24.
  24. MicroRNA-101 Suppresses Tumor Cell Proliferation by Acting as an Endogenous Proteasome Inhibitor via Targeting the Proteasome Assembly Factor POMP.
    Zhang X, Schulz R, Edmunds S, Krüger E, Markert E, Gaedcke J, Cormet-Boyaka E, Ghadimi M, Beissbarth T, Levine AJ, Moll UM, Dobbelstein M.
    Mol Cell. 2015 Jul 16;59(2):243-57.
  25. Genetic Polymorphisms in Endothelin-1 as Predictors for Long-Term Survival and the Cardiac Index in Patients Undergoing On-Pump Cardiac Surgery.
    Mansur A, Steinau M, Popov AF, Milenovic S, Bireta C, Weymann A, Schotola H, Wiese CH, Beissbarth T, Tzvetkov M, Hinz J.
    PLoS One. 2015 Jun 29;10(6):e0131155.
  26. Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study.
    Mansur A, Steinau M, Popov AF, Ghadimi M, Beissbarth T, Bauer M, Hinz J.
    BMC Med. 2015 Jun 1;13:128.
  27. Automated 3D-2D registration of X-ray microcomputed tomography with histological sections for dental implants in bone using chamfer matching and simulated annealing.
    Becker K, Stauber M, Schwarz F, Beißbarth T.
    Comput Med Imaging Graph. 2015 Sep;44:62-8.
  28. The CD14 rs2569190 TT Genotype Is Associated with an Improved 30-Day Survival in Patients with Sepsis: A Prospective Observational Cohort Study.
    Mansur A, Liese B, Steinau M, Ghadimi M, Bergmann I, Tzvetkov M, Popov AF, Beissbarth T, Bauer M, Hinz J.
    PLoS One. 2015 May 28;10(5):e0127761.
  29. pwOmics: an R package for pathway-based integration of time-series omics data using public database knowledge.
    Wachter A, Beißbarth T.
    Bioinformatics. 2015 Sep 15;31(18):3072-4.
  30. Chronic kidney disease is associated with a higher 90-day mortality than other chronic medical conditions in patients with sepsis.
    Mansur A, Mulwande E, Steinau M, Bergmann I, Popov AF, Ghadimi M, Beissbarth T, Bauer M, Hinz J.
    Sci Rep. 2015 May 21;5:10539.
  31. Preoperative Prediction of Lymph Node Status by Circulating Mir-18b and Mir-20a During Chemoradiotherapy in Patients with Rectal Cancer.
    Azizian A, Kramer F, Jo P, Wolff HA, Beißbarth T, Skarupke R, Bernhardt M, Grade M, Ghadimi BM, Gaedcke J.
    World J Surg. 2015 Sep;39(9):2329-35.
  32. HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer.
    Styczen H, Nagelmeier I, Beissbarth T, Nietert M, Homayounfar K, Sprenger T, Boczek U, Stanek K, Kitz J, Wolff HA, Ghadimi BM, Middel P, Liersch T, Rüschoff J, Conradi LC.
    Oncotarget. 2015 Jun 20;6(17):15065-76.
  33. 5-Fluorouracil sensitizes colorectal tumor cells towards double stranded DNA breaks by interfering with homologous recombination repair.
    Srinivas US, Dyczkowski J, Beißbarth T, Gaedcke J, Mansour WY, Borgmann K, Dobbelstein M.
    Oncotarget. 2015 May 20;6(14):12574-86.
  34. mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer.
    von der Heyde S, Wagner S, Czerny A, Nietert M, Ludewig F, Salinas-Riester G, Arlt D, Beißbarth T.
    Plos One, 2015, 10(2):e0117818.
  35. entifies regulators of the ErbB receptor signaling network
    Annabell Bischoff A, Bayerlová M, Strotbek M, Schmid S, Beißbarth T, Olayioye MA
    Cell Communication and Signaling, 2015, 3:5.
  36. High-grade acute organ toxicity and p16INK4A expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinoma.
    Tehrany N, Kitz J, Rave-Fränk M, Lorenzen S, Li L, Küffer S, Hess CF, Burfeind P, Reichardt HM, Canis M, Beißbarth T*, Wolff HA*.
    Strahlenther Onkol, 2015, 191(7):566-72.
  37. Primary bacteraemia is associated with a higher mortality risk compared with pulmonary and intra-abdominal infections in patients with sepsis: a prospective observational cohort study.
    Mansur A, Klee Y, Popov AF, Erlenwein J, Ghadimi M, Beißbarth T, Bauer M, Hinz J.
    BMJ Open, 2015, 5(1):e006616.
  38. Wnt/β-catenin signaling integrates patterning and metabolism of the insect growth zone.
    Oberhofer G, Grossmann D, Siemanowski JL, Beißbarth T, Bucher G.
    Development, 2014, 141(24):4740-50.
  39. Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancer.
    Gaedcke J, Leha A, Claus R, Weichenhan D, Jung K, Kitz J, Grade M, Wolff HA, Jo P, Doyen J, Gérard JP, Johnsen SA, Plass C, Beißbarth T, Ghadimi M.
    Oncotarget, 2014, 5(18):8123-35.
  40. UDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespib.
    Landmann H, Proia DA, He S, Ogawa LS, Kramer F, Beißbarth T, Grade M, Gaedcke J, Ghadimi M, Moll U, Dobbelstein M.
    Cell Death Dis, 2014, 5:e1411.
  41. RPPanalyzer toolbox: an improved R package for analysis of reverse phase protein array data.
    von der Heyde S, Sonntag J, Kaschek D, Bender C, Bues J, Wachter A, Timmer J, Korf U, Beißbarth T.
    Biotechniques, 2014, 57(3):125-35.
  42. Integrated miRNA and mRNA profiling of tumor-educated macrophages identifies prognostic subgroups in estrogen receptor-positive breast cancer.
    Bleckmann A, Leha A, Artmann S, Menck K, Salinas-Riester G, Binder C, Pukrop T, Beißbarth T*, Klemm F*.
    Mol Oncol, 2015, 9(1):155-66.
  43. Impact of frailty on short- and long-term morbidity and mortality after transcatheter aortic valve implantation: risk assessment by Katz Index of activities of daily living.
    Puls M, Sobisiak B, Bleckmann A, Jacobshagen C, Danner BC, Hünlich M, Beißbarth T, Schöndube F, Hasenfuß G, Seipelt R, Schillinger W.
    EuroIntervention, 2014, 10(5):609-19.
  44. Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients.
    Mannil M, Solari A, Leha A, Pelayo-Negro AL, Berciano J, Schlotter-Weigel B, Walter MC, Rautenstrauss B, Schnizer TJ, Schenone A, Seeman P, Kadian C, Schreiber O, Angarita NG, Fabrizi GM, Gemignani F, Padua L, Santoro L, Quattrone A, Vita G, Calabrese D; CMT-TRIAAL/CMT-TRAUK Group, Young P, Laurà M, Haberlová J, Mazanec R, Paulus W, Beißbarth T, Shy ME, Reilly MM, Pareyson D, Sereda MW.
    Neuromuscul Disord, 2014, 24(11):1003-17.
  45. Superior vena cava syndrome caused by a malignant tumor: a retrospective single-center analysis of 124 cases.
    Hohloch K, Bertram N, Trümper L, Beißbarth T, Griesinger F.
    J Cancer Res Clin Oncol, 2014, 140(12):2129-34.
  46. Failure of acute procedural success predicts adverse outcome after percutaneous edge-to-edge mitral valve repair with MitraClip.
    Puls M, Tichelbäcker T, Bleckmann A, Hünlich M, von der Ehe K, Beuthner BE, Rüter K, Beißbarth T, Seipelt R, Schöndube F, Hasenfuß G, Schillinger W.
    EuroIntervention, 2014, 9(12):1407-17.
  47. Boolean ErbB network reconstructions and perturbation simulations reveal individual drug response in different breast cancer cell lines.
    Von der Hyde S, Bender C, Henjes F, Sonntag J, Korf U, Beißbarth T.
    BMC Systems Biology 2014, 8:75.
  48. The regulatory toll-like receptor 4 genetic polymorphism rs11536889 is associated with renal, coagulation and hepatic organ failure in sepsis patients.
    Mansur A, von Gruben L, Popov AF, Steinau M, Bergmann I, Ross D, Ghadimi M, Beißbarth T, Bauer M, Hinz J.
    J Transl Med, 2014, 12(1):177.
  49. Dynamics of mRNA and polysomal abundance in early 3T3-L1 adipogenesis.
    von der Heyde S, Fromm-Dornieden C, Salinas-Riester G, Beißbarth T*, Baumgartner B*.
    BMC Genomics, 2014, 18;15:381.
  50. R-based software for the integration of pathway data into bioinformatic algorithms.
    Kramer F, Bayerlova M, Beißbarth T.
    Biology (Basel), 3(1):85-100, Review.
  51. Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: Updated results of the CAO/ARO/AIO-94 trial after a median follow-up of 11 years.
    Fokas E, Liersch T, Fietkau R, Hohenberger W, Beißbarth T, Hess C, Becker H, Ghadimi M, Mrak K, Merkel S, Raab HR, Sauer R, Wittekind C, Rödel C.
    Journal of Clinical Oncology, 2014, 32(15):1554-62.
  52. Adaption of the global test idea to proteomics data with missing values.
    Jung K, Dihazi H, Bibi A, Dihazi GH, Beißbarth T.
    Bioinformatics, 2014, 30(10):1424-30.
  53. Ninety-day survival rate of patients with sepsis relates to programmed cell death 1 genetic polymorphism rs11568821.
    Mansur A, Hinz J, Hillebrecht B, Bergmann I, Popov AF, Ghadimi M, Bauer M, Beißbarth T, Mihm S.
    J Investig Med, 2014, 62(3):638-43.
  54. TNF-α mediates mitochondrial uncoupling and enhances ROS-dependent cell migration via NF-κB activation in liver cells.
    Kastl L, Sauer SW, Ruppert T, Beißbarth T, Becker MS, Süss D, Krammer PH, Gülow K.
    FEBS Lett, 2014, 588(1):175-83.
  55. Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 study.
    Fokas E, Conradi L, Weiss C, Sprenger T, Middel P, Rau T, Dellas K, Kitz J, Rödel F, Sauer R, Rüschoff J, Beißbarth T, Arnold D, Ghadimi BM, Rödel C, Liersch T.
    Int J Radiat Oncol Biol Phys, 2013, 87(5):992-9.
  56. STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo.
    Spitzner M, Roesler B, Bielfeld C, Emons G, Gaedcke J, Wolff HA, Rave-Fränk M, Kramer F, Beißbarth T, Kitz J, Wienands J, Ghadimi BM, Ebner R, Ried T, Grade M.
    Int J Cancer, 2014, 134(4):997-1007.
  57. Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7g.
    Salendo J, Spitzner M, Kramer F, Zhang X, Jo P, Wolff HA, Kitz J, Kaulfuß S, Beißbarth T, Dobbelstein M, Ghadimi M, Grade M, Gaedcke J.
    Radiother Oncol, 2013, 108(3):451-7.
  58. Lymph node metastases in rectal cancer after preoperative radiochemotherapy: impact of intramesorectal distribution and residual micrometastatic involvement.
    Sprenger T, Rothe H, Becker H, Beißbarth T, Homayounfar K, Gauss K, Kitz J, Wolff H, Scheel AH, Ghadimi M, Rödel C, Conradi LC, Liersch T.
    Am J Surg Pathol, 2013, 37(8):1283-9.
  59. Connecting high-dimensional mRNA and miRNA expression data for binary medical classification problems.
    Fuchs M, Beißbarth T, Wingender E, Jung K.
    Comput Methods Programs Biomed, 2013, 111(3):592-601.
  60. Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: long-term results of the German CAO/ARO/AIO-94 phase III trial.
    Wolff HA, Conradi LC, Beißbarth T, Leha A, Hohenberger W, Merkel S, Fietkau R, Raab HR, Tschmelitsch J, Hess CF, Becker H, Wittekind C, Sauer R, Rödel C, Liersch T; German Rectal Cancer Study Group.
    Radiother Oncol, 2013, 108(1):48-54.
  61. Estimating learning outcomes from pre- and posttest student self-assessments: a longitudinal study.
    Schiekirka S, Reinhardt D, Beißbarth T, Anders S, Pukrop T, Raupach T.
    Acad Med, 2013, 88(3):369-75.
  62. Genetic amplication of the NOTCH modulator LNX2 upregulates the WNT/β-catenin pathway in colorectal cancer
    Camps J, Pitt JJ, Emons G, Hummon AB, Case CM, Grade M, Jones TL, Nguyen QT, Ghadimi BM, Beißbarth T, Difilippantonio MJ, Caplen NJ, Ried T
    Cancer Res, 2013, 73(6):2003-13.
  63. Frequency of HER-2 Positivity in Rectal Cancer and Prognosis.
    Conradi LC, Styczen H, Sprenger T, Wolff HA, Rödel C, Nietert M, Homayounfar K, Gaedcke J, Kitz J, Talaulicar R, Becker H, Ghadimi M, Middel P, Beißbarth T, Rüschoff J, Liersch T.
    Am J Surg Pathol, 2012, 37(4):522-31.
  64. rBiopaxParser--an R package to parse, modify and visualize BioPAX data.
    Kramer F, Bayerlová M, Klemm F, Bleckmann A, Beißbarth T.
    Bioinformatics, 2013, 29(4):520-2.
  65. Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-Catenin in cerebral metastasis of lung adenocarcinomas.
    Bleckmann A, Siam L, Klemm F, Rietkötter E, Wegner C, Kramer F, Beißbarth T, Binder C, Stadelmann C, Pukrop T.
    Clin Exp Metastasis, 2012, 30(4):471-82.
  66. Inactivation of Patched1 in Mice Leads to Development of Gastrointestinal Stromal-Like Tumors That Express Pdgfrα but Not Kit.
    Pelczar P, Zibat A, van Dop WA, Heijmans J, Bleckmann A, Gruber W, Nitzki F, Uhmann A, Guijarro MV, Hernando E, Dittmann K, Wienands J, Dressel R, Wojnowski L, Binder C, Taguchi T, Beißbarth T, Hogendoorn PC, Antonescu CR, Rubin BP, Schulz-Schaeffer W, Aberger F, van den Brink GR, Hahn H.
    Gastroenterology, 2012, 144(1):134-144.e6.
  67. Extrinsic and intrinsic regulation of DOR/TP53INP2 expression in mice: effects of dietary fat content, tissue type and sex in adipose and muscle tissues.
    Fromm-Dornieden C, Lytovchenko O, von der Heyde S, Behnke N, Hogl S, Berghoff J, Köpper F, Opitz L, Renne U, Hoeflich A, Beißbarth T, Brenig B, Baumgartner BG.
    Nutr Metab, 2012, 9(1):86.
  68. Cohesin is required for expression of the estrogen receptor-alpha (ESR1) gene.
    Prenzel T, Kramer F, Bedi U, Nagarajan S, Beißbarth T, Johnsen SA.
    Epigenetics Chromatin, 2012, 5(1):13.
  69. The rectal cancer microRNAome--microRNA expression in rectal cancer and matched normal mucosa.
    Gaedcke J, Grade M, Camps J, Søkilde R, Kaczkowski B, Schetter AJ, Difilippantonio MJ, Harris CC, Ghadimi BM, Møller S, Beißbarth T, Ried T, Litman T.
    Clin Cancer Res, 2012, 18(18):4919-30.
  70. Piloting an outcome-based programme evaluation tool in undergraduate medical education.
    Raupach T, Schiekirka S, Münscher C, Beißbarth T, Himmel W, Burckhardt G, Pukrop T.
    GMS Z Med Ausbild, 2012, 29(3):Doc44.
  71. Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival.
    Sprenger T, Conradi LC, Beißbarth T, Ermert H, Homayounfar K, Middel P, Rüschoff J, Wolff HA, Schüler P, Ghadimi BM, Rödel C, Becker H, Rödel F, Liersch T.
    Cancer, 2013, 119(1):26-35.
  72. Detection of simultaneous Group Effects in microRNA Expression and related Target Gene Sets.
    Artmann S, Jung K, Bleckmann A, Beißbarth T.
    PLoS ONE, 2012, 7(6):e38365.
  73. The Histone H2B Monoubiquitination Regulatory Pathway Is Required for Differentiation of Multipotent Stem Cells.
    Karpiuk O, Najafova Z, Kramer F, Hennion M, Galonska C, König A, Snaidero N, Vogel T, Shchebet A, Begus-Nahrmann Y, Kassem M, Simons M, Shcherbata H, Beissbarth T, Johnsen SA.
    Mol Cell, 2012, 46(5):705-13.
  74. German medical students lack knowledge of how to treat smoking and problem drinking.
    Strobel L, Schneider NK, Krampe H, Beißbarth T, Pukrop T, Anders S, West R, Aveyard P, Raupach T.
    Addiction, 2012, 107(10):1878-82.
  75. A new analysis approach of epidermal growth factor receptor pathway activation patterns provides insights into cetuximab resistance mechanisms in head and neck cancer.
    von der Heyde S, Beißbarth T.
    BMC Medicine, 2012, 10(1):43.
  76. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: Results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow up of 11 years.
    Sauer R, Liersch T, Merkel S, Villanueva MT, Fietkau R, Hohenberger W, Hess C, Becker H, Raab HR, Witzigmann H, Wittekind C, Beißbarth T, Rödel C.
    Journal of Clinical Oncology, 2012, 30(16):1926-33.
  77. Novel polysome messages and changes in translational activity appear after induction of adipogenesis in 3T3-L1 cells.
    Fromm-Dornieden C, Heyde S, Lytovchenko O, Salinas-Riester G, Brenig B, Beißbarth T, Baumgartner BG.
    BMC Molecular Biology, 2012, 13:9.
  78. Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatment.
    Homayounfar K, Bleckmann A, Conradi LC, Sprenger T, Beißbarth T, Lorf T, Niessner M, Sahlmann CO, Meller J, Becker H, Liersch T, Ghadimi BM.
    Int J Colorectal Dis, 2012, 27(10):1359-67.
  79. Effects of Pulmonary Acid Aspiration on the lungs and extra-pulmonary organs: A randomized study in pigs.
    Heuer JF, Sauter P, Pelosi P, Herrmann P, Brück W, Perske C, Schoendube F, Crozier TA, Bleckmann A, Beißbarth T, Quintel M
    Critical Care, 2012, 16(2):R35.
  80. Systems-wide RNAi analysis of CASP8AP2/FLASH shows transcriptional deregulation of the replication-dependent histone genes and extensive effects on the transcriptome of colorectal cancer cells.
    Hummon AB, Pitt JJ, Camps J, Emons G, Skube SB, Huppi K, Jones TL, Beißbarth T, Kramer F, Grade M, Difilippantonio MJ, Ried T, Caplen NJ.
    Molecular Cancer, 2012, 11(1):1.
  81. Strong EGFR-mediated signaling in ERBB2-amplified breast cancer cell line models attenuates response to ERBB2-targeting drugs.
    Henjes F, Bender C, von der Heyde S, Braun L, Mannsperger HA, Schmidt C, Wiemann S, Hasmann M, Aulmann S, Beißbarth T, Korf U.
    Oncogenesis, 2012, 1:e16.
  82. Graph based fusion of miRNA and mRNA expression data improves clinical outcome prediction in prostate cancer.
    Gade S, Porzelius C, Fälth M, Brase JC, Wuttig D, Kuner R, Binder H, Sültmann H, Beißbarth T.
    BMC Bioinformatics, 2011, 12(1):488.
  83. TMPRSS2-ERG-specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-beta signaling.
    Brase JC, Johannes M, Mannsperger H, Fälth M, Metzger J, Kacprzyk LA, Andrasiuk T, Gade S, Meister M, Sirma H, Sauter G, Simon R, Schlomm T, Beißbarth T, Korf U, Kuner R, Sültmann H.
    BMC Cancer, 2011, 11(1):507.
  84. CpG island methylator phenotype infers a poor prognosis in locally advanced rectal cancer.
    Jo P, Jung K, Grade M, Conradi LC, Wolff HA, Kitz J, Rüschoff J, Hartmann A, Becker H, Beißbarth T, Müller A, Ghadimi MB, Schneider-Stock R, Gaedcke R.
    Surgery, 2012, 151(4):564-70.
  85. Acute Toxicity of Radiochemotherapy in Rectal Cancer Patients: A Risk Particularly for Carriers of the TGFB1 Pro25 variant.
    Schirmer MA, Nadine Mergler CP, Rave-Fränk M, Herrmann MK, Hennies S, Gaedcke J, Conradi LC, Jo P, Beißbarth T, Hess CF, Becker H, Ghadimi M, Brockmöller J, Christiansen H, Wolff HA.
    Int J Radiat Oncol Biol Phys, 2012, 83(1):149-57.
  86. Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy.
    Kendziorra E, Ahlborn K, Spitzner M, Rave-Fränk M, Emons G, Gaedcke J, Kramer F, Wolff HA, Becker H, Beißbarth T, Ebner R, Ghadimi BM, Pukrop T, Ried T, Grade M.
    Carcinogenesis, 2011, 32(12):1824-31.
  87. Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B.
    Prenzel T, Begus-Nahrmann Y, Kramer F, Hennion M, Hsu C, Gorsler T, Hintermair C, Eick D, Kremmer E, Simons M, Beißbarth T, Johnsen SA.
    Cancer Research, 2011, 71(17):5739-53.
  88. Towards outcome-based programme evaluation: Using student comparative self-assessments to determine teaching effectiveness.
    Raupach T, Münscher C, Beißbarth T, Burckhardt G, Pukrop T.
    Med Teach; 2011; 33(8):e446-e453.
  89. Inferring signalling networks from longitudinal data using sampling based approaches in the R-package 'ddepn'.
    Bender C, Heyde S, Henjes F, Wiemann S, Korf U, Beißbarth T.
    BMC Bioinformatics 2011, 12:291.
  90. Reporting FDR analogous confidence intervals for the log fold change of differentially expressed genes.
    Jung K, Friede T, Beißbarth T.
    BMC Bioinformatics, 2011, 12:288.
  91. Effects of High-frequency Oscillatory Ventilation on Systemic and Cerebral Hemodynamics and Tissue Oxygenation: An Experimental Study in Pigs.
    Heuer JF, Sauter P, Barwing J, Herrmann P, Crozier TA, Bleckmann A, Beißbarth T, Moerer O, Quintel M.
    Neurocrit Care, 2012, 17(2):281-92.
  92. Gender-specific acute organ toxicity during intensified preoperative radiochemotherapy for rectal cancer.
    Wolff HA, Conradi LC, Schirmer M, Beißbarth T, Sprenger T, Rave-Fränk M, Hennies S, Hess CF, Becker H, Christiansen H, Liersch T.
    Oncologist, 2011, 16(5):621-31.
  93. Sequential Interim Analyses of Survival Data in DNA Microarray Experiments.
    Leha A, Beißbarth T, Jung K.
    BMC Bioinformatics, 2011, 12(1):127.
  94. pathClass: an R-package for integration of pathway knowledge into support vector machines for biomarker discovery.
    Johannes M, Fröhlich H, Sültmann H, Beißbarth T.
    Bioinformatics, 2011, 27(10):1442-3.
  95. Comparison of Global Tests for Functional Gene Sets in Two-Group Designs and Selection of Potentially Effect-causing Genes.
    Jung K, Becker B, Brunner B, Beißbarth T.
    Bioinformatics, 2011, 27(10):1377-83.
  96. Thymidylate Synthase as a Prognostic Biomarker for Locally Advanced Rectal Cancer after multimodal Treatment.
    Conradi LC, Bleckmann A, Schirmer M, Sprenger T, Jo P, Homayounfar K, Wolff HA, Rothe H, Middel P, Becker H, Ghadimi MB, Beißbarth T, Liersch T.
    Ann Surg Oncol, 2011, 18(9):2442-52.
  97. Leveraging external knowledge on molecular interactions in classification methods for risk prediction of patients.
    Porzelius C, Johannes M, Binder H, Beißbarth T.
    Biometrical Journal, 2011, 53(2):190-201.
  98. b-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis.
    Klemm F, Bleckmann A, Siam L, Chuang HN, Rietkötter E, Behme D, Schulz M, Schaffrinski M, Schindler S, Trümper L, Kramer F, Beißbarth T, Stadelmann C, Binder C, Pukrop T.
    Carcinogenesis, 2011, 32(3):434-42.
  99. Failure of down-regulation of Survivin following neoadjuvant radiochemotherapy in rectal cancer is associated with distant metastases and shortened survival.
    Sprenger T, Rödel F, Beißbarth T, Conradi LC, Rothe H, Homayounfar K, Wolff HA, Ghadimi BM, Yildirim M, Becker H, Rödel C, Liersch T.
    Clinical Cancer Research, 2010, 17(6):1623-31.
  100. A Gene Expression Signature for Chemoradiosensitivity of Colorectal Cancer Cells.
    Spitzner M, Emons G, Kramer F, Gädcke J, Rave-Fränk M, Scharf JG, Burfeind P, Becker H, Beißbarth T, Ghadimi BM, Ried T, Grade M.
    Int J Radiat Oncol, 2010, 78(4):1184-92.
  101. Dynamic Deterministic Effect Propagation Networks: learning signalling pathways from longitudinal protein array data.
    Bender C, Henjes F, Fröhlich H, Wiemann S, Korf U, Beißbarth T.
    Bioinformatics, 2010, 26(18):i596-602.
  102. Mutated KRAS Results in Overexpression of DUSP4, a MAP-Kinase Phosphatase, and SMYD3, a Histone Methyltransferase, in Rectal Carcinomas.
    Gaedcke J, Grade M, Jung K, Camps J, Jo P, Emons G, Gehoff A, Sax U, Schirmer M, Becker H, Beißbarth T, Ried T, Ghadimi BM.
    Gene Chromosome Canc, 2010, 49(11):1024-34.
  103. QuantProReloaded: Quantitative Analysis of Microspot Immunoassays.
    Jöcker A, Sonntag J, Henjes F, Goetschel F, Tresch A, Beißbarth T, Wiemann S, Korf U.
    Bioinformatics, 2010, 26(19):2480-1.
  104. Impact of RNA degradation on gene expression profiling.
    Opitz L, Salinas-Riester G, Grade M, Jung K, Jo P, Emons G, Ghadimi BM, Beißbarth T*, Gaedcke J*.
    BMC Medical Genomics, 2010, 3:36.
  105. Spatio-temporal regulation of multiple overlapping sense and novel natural antisense transcripts at the Nrgn and Camk2n1 gene loci during mouse cerebral corticogenesis.
    Ling KH, Hewitt CA, Banerjee K, Cheah PS, Beißbarth T, Hyde L, Smyth GK, Tan SS, Hahn CN, Thomas T, Thomas PQ, Scott HS.
    Cerebral Cortex, 2010, 21(3):683-97.
  106. Comprehensive, Quantitative Mapping of T Cell Epitopes in Gluten in Celiac Disease.
    Tye-Din J*, Stewart JA*, Dromey JA*, Beißbarth T*, van Heel DA, Tatham A, Henderson K, Mannering SI, Gianfrani C, Jewell DP, Hill AVS, McCluskey J, Rossjohn J, Anderson RP.
    Science Translational Medicine, 2010, 2(41):41ra51.
  107. RPPanalyzer: Analysis of reverse phase protein array data.
    Mannsperger H, Gade S, Wiemann S, Sültmann H, Beißbarth T, Korf U.
    Bioinformatics, 2010, 26(17):2202-3.
  108. Integration Of Pathway Knowledge Into A Reweighted Recursive Feature Elimination Approach For Risk Stratification Of Cancer Patients.
    Johannes M, Brase JC, Fröhlich H, Gade S, Gehrman M, Fälth M, Sültmann H, Beißbarth T.
    Bioinformatics, 2010, 26(17):2136-44.
  109. Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification.
    Brase JC, Mannsperger H, Fröhlich H, Gade S, Schmidt C, Wiemann S, Beißbarth T, Schlomm T, Sültmann H and Korf U.
    Proteome Science, 2010, 8(1):36.
  110. Identification of NOL5A and RPS2 as potential therapeutic targets in colorectal cancer using a functional genomics approach.
    Grade M, Hummon AB, Emons G, Camps J, Spitzner M, Hörmann P, Gädcke J, Becker H, Ghadimi BM, Beißbarth T, Difilippantonio MJ, Caplen N, and Ried T.
    Int J Cancer, 2010, 128(5):1069-79.
  111. Circulating miRNAs are correlated with tumor progression in prostate cancer.
    Brase JC, Johannes M, Schlomm T, Fälth M, Häse A, Steuber T, Beißbarth T, Kuner R, Sültmann H.
    Int J Cancer, 2010, 128(3):608-16.
  112. A new sensitivity-preferred strategy to build prediction rules for therapy response of cancer patients using gene expression data.
    Jung K, Grade M, Gädcke J, Jo P, Opitz L, Becker H, Ghadimi BM, Beißbarth T.
    Comput Methods and Programs Biomed, 2010, 100(2):132-9.
  113. SAGE Analysis of Genes Differentially Expressed in Presymptomatic TgSOD1(G93A) Transgenic Mice Identified Cellular Processes Involved in Early Stage of ALS Pathology.
    Guipponi M, Li QX, Hyde L, Beißbarth T, Smyth GK, Masters CL, Scott HS.
    J Mol Neurosci. 2010, 41(1):172-82.
  114. KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy.
    Gaedcke J, Grade M, Jung K, Schirmer M, Jo P, Obermeyer C, Wolff HA, Herrmann MK, Beißbarth T, Becker H, Ried T, Ghadimi M.
    Radiother Oncol. 2009, 94(1):76-81.
  115. Preoperative Chemoradiotherapy Dös Not Necessarily Reduce Lymph Node Retrieval in Rectal Cancer Specimens-Results from a Prospective Evaluation with Extensive Pathological Work-up.
    Sprenger T, Rothe H, Homayounfar K, Beißbarth T, Ghadimi BM, Becker H, Liersch T.
    J Gastrointest Surg. 2009, 14(1):96-103.
  116. Deterministic Effects Propagation Networks for Reconstructing Protein Signaling Networks from Multiple Interventions.
    Fröhlich H, Sahin Ö, Arlt D, Bender C, Beißbarth T.
    BMC Bioinformatics, 2009, 10(10):R104.
  117. Molecular networks involved in mouse cerebral corticogenesis and spatio-temporal regulation of Sox4 and Sox11 novel antisense transcripts revealed by transcriptome profiling.
    Ling KH, Hewitt CA, Beißbarth T, Hyde L, Banerjee K, Cheah PS, Cannon PZ, Hahn CN, Thomas PQ, Smyth GK, Tan SS, Thomas S, Scott HS. Genome Biology, 2009, 10(10):R104.
  118. A Serial Analysis of Gene Expression (SAGE) profile of the Alzheimer's disease Tg2576 mouse model.
    George AJ, Gordon L, Beißbarth T, Koukoulas I, Holsinger DRM, Perreau V, Cappai R, Tan SS, Masters CL, Scott HS, Li QX.
    Neurotoxicity Research, 2010, 17(4):360-79.
  119. Nested Effects Models for Learning Signaling Networks from Perturbation Data.
    Fröhlich H, Tresch A, Beißbarth T
    Biometrical Journal, 2009, 51(2):304-23.
  120. Modeling ERBB receptor-regulated G1/S transition to find novel targets for de-novo trastuzumab resistance.
    Sahin Ö, Fröhlich H, Löbke C, Korf U, Burmester S, Majety M, Mattern J, Schupp I, Chaouiya C, Thieffry D, Poustka A, Wiemann S, Beißbarth T,Arlt D.
    BMC Systems Biology, 2009, 3(1):1.
  121. Extending pathways with inferred regulatory interactions from microarray data and protein domain signatures.
    Bender C, Fröhlich H, Johannes M, Beißbarth T.
    Proceedings of CAMDA, 2008.
  122. Relapse-free survival in breast cancer patients is associated with a gene expression signature characteristic for inflammatory breast cancer.
    Van Laere S, Beißbarth T, Auwera VI, Eynden VG, Trinh XB, Elst H, Hummelen P, Dam P, Marck E, Vermeulen P, Dirix L.
    Clin Cancer Res, 2008, 14(22):7452-60.
  123. Distinct transcriptional MYC(N) activities are associated with spontaneous regression or malignant progression in neuroblastomas.
    Westermann F, Muth D, Benner A, Bauer T, Henrich KO, Oberthür A, Brors B, Beißbarth T, Vandesompele J, Pattyn F, Hero B, König R, Fischer M, Schwab M.
    Genome Biology, 2008, 9(10):R150.
  124. Quantitative protein microarrays for time-resolved measurements of protein phosphorylation.
    Korf U, Derdak S, Tresch A, Henjes F, Schumacher S, Schmidt C, Hahn B, Lehmann W, Poustka A, Beißbarth T, Klingmüller U.
    Proteomics, 2008, 8(21):4603-12.
  125. Analyzing Gene Perturbation Screens With Nested Effects Models in R and Bioconductor
    Fröhlich H, Beißbarth T, Tresch A, Kostka D, Jacob J, Spang R, Markowetz F.
    Bioinformatics, 2008, 24(21):2549-50.
  126. Predicting Pathway Membership via Domain Signatures
    Fröhlich H, Fellmann M, Sültmann H, Poustka A, Beißbarth T
    Bioinformatics, 2008, 24(19):2137-42.
  127. Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer.
    Calabro A*, Beißbarth T*, Kuner R, Stojanov M, Benner A, Asslaber M, Ploner F, Zatloukal K, Samonigg H, Poustka A, Sültmann H.
    Breast Cancer Res Treat, 2008, 116(1):69-77.
  128. Antibody microarrays as an experimental platform for the analysis of signal transduction networks.
    Korf U, Henjes F, Schmidt C, Tresch A, Mannsperger H, Löbke C, Beißbarth T, Poustka A.
    Adv Biochem Eng Biotechnol. 2008;110:153-75.
  129. Estimating Large Scale Signaling Networks through Nested Effects Models from Intervention Effects in Microarray Data.
    Fröhlich H, Fellmann M, Sültmann H, Poustka A, Beißbarth T.
    Bioinformatics, 2008, 24(22):2650-6.
  130. Integrative analysis of RUNX1 downstream pathways and target genes.
    Michaud J, Simpson KM, Escher R, Buchet-Poyau K, Beißbarth T, Carmichel C, Ritschie ME, Schutz F, Cannon P, Liu M, Shen X, Ito Y, Raskind WH, Horwitz MS, Sato M, Urner DR, Speed TP, Kavallaris M, Smyth GK, Scott HS.
    BMC Genomics, 2008, 9:363.
  131. Extending pathways based on gene lists using InterPro domain signatures.
    Hahne FM, Mehrle A, Arlt D, Poustka A, Wiemann S, Beißbarth T.
    BMC Bioinformatics, 2008, 9:3.
  132. Modeling breast cell cycle regulation - overcoming drug resistance.
    Arlt D, Sahin Ö, Korf U, Löbke C, Beißbarth T, Hahne F, Wiemann S, Poustka A
    Conf Proc IEEE Eng Med Biol Soc. 2006;1:40-3.
  133. Large Scale Statistical Inference of Signaling Pathways from RNAi and Microarray Data.
    Fröhlich H, Fellmann M, Sültmann H, Poustka A, Beißbarth T
    BMC Bioinformatics, 2007, 8(1):386.
  134. Discrimination of direct and in direct interactions in a network of regulatory effect.
    Tresch A, Beißbarth T, Sültmann H, Kuner R, Poustka A, Buness A.
    Journal of Computational Biology, 2007, 14(9):1217-28.
  135. Estimating Large Scale Signaling Networks through Nested Effects Models from Intervention Effects in Microarray Data.
    Fröhlich H, Fellmann M, Sültmann H, Poustka A, Beißbarth T
    Proc. German Conf. Bioinformatics (GCB), 2007, 45-54.
  136. A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease.
    Henderson KN, Tye-Din JA, Reid HH, Chen Z, Borg NA, Beißbarth T, Tatham A, Mannering SI, Purcell AW, Dudek NL, van Heel DA, McCluskey J, Rossjohn J, Anderson RP.
    Immunity. 7.2007; 27(1):23-34.
  137. GOSim - an R-package for computation of information theoretic GO similarities between terms and gene products.
    Fröhlich H, Speer N, Poustka A, Beißbarth T.
    BMC Bioinformatics. 5.2007 8:166.
  138. Interpreting experimental results using gene ontologies.
    Beißbarth T
    Methods Enzymol. 2006;411:340-52.
  139. Nedd4-WW domain-binding protein 5 (Ndfip1) is associated with neuronal survival after acute cortical brain injury
    Sang Q, Kim MH, Kumar S, Bye N, Morganti-Kossman MC, Gunnersen J, Fuller S, Howitt J, Hyde L, Beißbarth T, Scott HS, Silke J, Tan SS
    J Neurosci. 2006, 26(27), 7234-44.
  140. Modelling and analysis of T-cell epitope screening data
    Beißbarth T, Tye-Din JA, Smyth GK, Anderson RP, Speed TP
    Proceedings of the 20th International Workshop on Statistical Modelling, 2005, 101-109.
  141. A systematic approach for comprehensive T-cell epitope discovery using peptide libraries.
    Beißbarth T, Tye-Din JA, Smyth GK, Speed TP, Anderson RP
    Bioinformatics; 7.2005; 21(ISMB Supplement 1), i29-37.
  142. A comparative analysis of transcribed genes in the mouse hypothalamus and neocortex reveals chromosomal clustering
    Boon WM, Beißbarth T, Hyde L, Smyth GK, Gunnersen J, Denton DA, Scott HS, Tan SS
    Proc Natl Acad Sci USA; 10.2004; 101(21); 14972-14977.
  143. Statistical modeling of seqüncing errors in SAGE libraries
    Beißbarth T, Hyde L, Smyth GK, Job C, Boon WM, Tan SS, Scott HS, Speed TP
    Bioinformatics; 7.2004; 20(ISMB Supplement 1), I31-I39.
  144. GOstat: Find statistically overrepresented Gene Ontologies within a group of genes
    Beißbarth T, Speed TP
    Bioinformatics, 6.2004; 20(9): 1464-1465.
  145. Analysis of CREM-dependent gene expression during mouse spermatogenesis
    Beißbarth T, Borisevich I, Hörlein A, Kenzelmann M, Hergenhahn M, Klewe-Nebenius A, Klären R, Korn B, Schmid W, Vingron M, Schütz G
    Molecular and Cellular Endocrinology; 12.2003; 212(1-2): 29-39.
  146. Monitoring the switch from housekeeping to pathogen defence metabolism in Arabidopsis thaliana using cDNA arrays
    Scheideler M, Schlaich NL, Fellenberg K, Beißbarth T, Hauser NC, Vingron M, Slusarenko AJ, Hoheisel JD
    Journal of Biological Chemistry; 3.2002; 277(12): 10555-10561.
  147. GeneNest: automated generation and visualization of gene indices
    Haas S, Beißbarth T, Rivals E, Krause A, Vingron M
    Trends in Genetics; 11.2000; 16(11):521-523.
  148. Processing and quality control of DNA array hybridization data
    Beißbarth T, Fellenberg K, Brors B, Arribas-Prat R, Bör JM, Hauser NC, Scheideler M, Hoheisel JD, Schütz G, Poustka A, Vingron M
    Bioinformatics; 11.2000; 16(11): 1014-1022.
  149. Increased Efficiency of Folding and Peptide Loading of Mutant MHC Class I Molecules;
    Beißbarth T, Sun J, Kavathas PB, Ortmann B
    European Journal of Immunology; 4.2000; 30(4): 1203-1213.

Address

Prof. Dr. Tim Beißbarth
Statistical Bioinformatics (Dept. Medical Statistics)
Humboldtallee 32
37073 Göttingen / Germany
Phone: +49 551 39175274
Fax: +49 551 394995
Email: tim.beissbarth@ams.med.uni-goettingen.de